Population‐based screening for prostate cancer by measuring free and total serum prostate‐specific antigen in Sweden

Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening

1993 • 1,014 citations

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

1991 • 954 citations

Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate Examination

1997 • 675 citations

Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer

1993 • 660 citations

The TNM classification of prostate cancer

1992 • 475 citations

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

1995 • 467 citations

Making the most out of six systematic sextant biopsies

1995 • 440 citations

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers

1993 • 309 citations

Management of Cancer of the Prostate

1994 • 303 citations

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1995 • 294 citations

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

1996 • 208 citations

Long-term Survival and Mortality in Prostate Cancer Treated with Noncurative Intent

1995 • 197 citations

Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex

1995 • 193 citations

Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands

1983 • 188 citations

Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum

1995 • 175 citations

Second stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994

1995 • 148 citations

CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGEN

1998 • 141 citations

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men

1995 • 110 citations

Patient Age as a Prognostic Factor in Prostate Cancer

1994 • 106 citations

Diagnostic Methods in the Detection of Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

1992 • 93 citations

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density

1995 • 81 citations

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

1996 • 77 citations

Prostate‐specific antigen lewels in 1695 men without evidence of prostate cancer: Findings of the American cancer society national prostate cancer detection project

1992 • 52 citations